Inventor · disambiguated record
Jerome Aubert
Also filed as: AUBERT JEROME · AUBERT JERÔME · AUBERT JÉRÔME
15 granted patents·26 pending applications·11 citations·filing 2002–2018
86Inventor score
Top patents by PatentIndex Score
41 records- 0182US7625914B2Compounds that modulate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereofGALDERMA RES & DEV·Filed 2005·Granted Dec 1, 2009·5 cites·38 claims
- 0276US9090596B2Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologiesGALDERMA RES & DEV·Filed 2012·Granted Jul 28, 2015·3 cites·9 claims
- 0370US9580412B2Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseasesGALDERMA RES & DEV·Filed 2016·Granted Feb 28, 2017·1 cites·11 claims
- 0468US9526732B2Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologiesGALDERMA RES & DEV·Filed 2015·Granted Dec 27, 2016·1 cites·8 claims
- 0567US9388149B2Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseasesGALDERMA RES & DEV·Filed 2012·Granted Jul 12, 2016·1 cites·10 claims
- 0665US8022079B2Methods of modulating PPAR gamma-type receptorsGALDERMA RES & DEV·Filed 2009·Granted Sep 20, 2011·0 cites·34 claims
- 0765US7968560B2Compounds that modulate PPARγ-type receptors and cosmetic/pharmaceutical compositions comprising said compoundsGALDERMA RES & DEV·Filed 2009·Granted Jun 28, 2011·0 cites·31 claims
- 0861US9889126B2Use of naratriptan in the treatment of rosaceaGALDERMA RES & DEV·Filed 2014·Granted Feb 13, 2018·0 cites·16 claims
- 0961US7973063B2Methods for activating PPAR gamma-type receptorsGALDERMA RES & DEV·Filed 2009·Granted Jul 5, 2011·0 cites·37 claims
- 1056US7626054B2Biaromatic compounds which activate PPARγ-type receptors and cosmetic/pharmaceutical compositions comprised thereofGALDERMA RES & DEV·Filed 2006·Granted Dec 1, 2009·0 cites·56 claims
- 1156US2011263677A1Gos2 modulators in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoeaGALDERMA RES & DEV·Filed 2009·Application pending·0 cites
- 1255US10125400B2Method for the diagnosis of rosaceaGALDERMA RES & DEV·Filed 2013·Granted Nov 13, 2018·0 cites·20 claims
- 1355US2009104263A15-HT4 partial agonist pharmaceutical compositionsAUBERT JEROME·Filed 2008·Application pending·0 cites
- 1454US2011268742A1Pctp modulators in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoeaGALDERMA RES & DEV·Filed 2009·Application pending·0 cites
- 1552US2019242874A1Human epithelial cell line for 3-d modelizing of cancer and treatment thereofGALDERMA RES & DEV·Filed 2018·Application pending·0 cites
- 1650US2011165168A1Cidea modulators in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoeaGALDERMA RES & DEV·Filed 2009·Application pending·0 cites
- 1750US2011150773A1Modulators of acetyl-coenzyme a acyltransferase 1 or 2 in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoeaGALDERMA RES & DEV·Filed 2009·Application pending·0 cites
- 1849US9120772B2Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseasesGALDERMA RES & DEV·Filed 2012·Granted Sep 1, 2015·0 cites·6 claims
- 1949US2010168089A1Utilization of tace inhibitors for the treatment of acneGALDERMA RES & DEV·Filed 2009·Application pending·0 cites
- 2049US2011262451A1Modulators of isovaleryl-coenzyme a dehydrogenase in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoeaAUBERT JEROME·Filed 2009·Application pending·0 cites
- 2148US2010021893A1Modulators of lanosterol synthetase for treating acne or hyperseborrheaGALDERMA RES & DEV·Filed 2009·Application pending·0 cites
- 2248US2011229423A1Pacap signaling pathway modulators for treating inflammatory skin diseases having a neurogenic component, notably rosacea, and compositions comprised thereofGALDERMA RES & DEV·Filed 2009·Application pending·0 cites
- 2348US2009246776A1Modulators of scarb-1 for treating acne or hyperseborrheaGALDERMA RES & DEV·Filed 2009·Application pending·0 cites
- 2447US2011189686A1Screening for modulators of cyp2b15 and/or gpd1 for the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoeaGALDERMA RES & DEV·Filed 2009·Application pending·0 cites
- 2547US2014031341A1Modulators and methods for the treatment of rosaceaAUBERT JEROME·Filed 2011·Application pending·0 cites
- 2647US2010028879A1Modulators of HSD17b7 for treating acne or hyperseborrheaGALDERMA RES & DEV·Filed 2009·Application pending·0 cites
- 2746US2005106236A15-Ht4partial agonist pharmaceutical compositionsFiled 2002·Application pending·0 cites
- 2845US8086412B2Corrective methodology for processing results of transcriptome experiments obtained by differential analysisFOGEL PAUL·Filed 2009·Granted Dec 27, 2011·0 cites·9 claims
- 2945US2011213009A1Adfp modulators in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoeaGALDERMA RES & DEV·Filed 2009·Application pending·0 cites
- 3045US2016000800A1Modulators and methods for the treatment of rosaceaGALDERMA RES & DEV·Filed 2015·Application pending·0 cites
- 3145US2017023549A1Human epithelial cell line for 3-d modelizing of cancer and treatment thereofGALDERMA RES & DEV·Filed 2016·Application pending·0 cites
- 3245US2010021892A1Modulators of SC4MOL for treating acne or hyperseborrheaGALDERMA RES & DEV·Filed 2009·Application pending·0 cites
- 3343US2013231393A1Use of squaramide in the prevention and/or treatment of rosaceaAUBERT JEROME·Filed 2011·Application pending·0 cites
- 3443US2014243523A1Human epithelial cell line for 3-d modelizing of cancer and treatment thereofCENTRE NAT RECH SCIENT·Filed 2012·Application pending·0 cites
- 3542US9415039B2Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseasesGALDERMA RES & DEV·Filed 2015·Granted Aug 16, 2016·0 cites·8 claims
- 3641US2010233718A1Non-invasive technique for conducting skin inflammatory disease pharmaco-genomic studies and diagnoses thereofGALDERMA RES & DEV·Filed 2010·Application pending·0 cites
- 3739US2013017969A1Markers and method for the diagnosis of rosaceaUNI MUNSTER·Filed 2010·Application pending·0 cites
- 3838US2014024725A1Modulators for trpa1 for the treatment of rosaceaAUBERT JEROME·Filed 2011·Application pending·0 cites
- 3936US2013005803A1Use of compounds in the treatment or prevention of skin disordersGALDERMA RES & DEV·Filed 2010·Application pending·0 cites
- 4036US2014275108A1Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmeticsGALDERMA RES & DEV·Filed 2013·Application pending·0 cites
- 4128US8044082B2N-phenylacetamide inhibitors of the enzyme SOAT-1 and pharmaceutical/cosmetic compositions comprised thereofGALDERMA RES & DEV·Filed 2010·Granted Oct 25, 2011·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when Jerome Aubert files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →